Results 151 to 160 of about 392,833 (299)

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control

Clinical, Cosmetic and Investigational Dermatology
Maoying Li,1 Xi Wang,2 Jiehui Chen,2 Tao Deng,2 Cuihong Lian3 1Department of Dermatology and Venereology,Guanxi University of Chinese Medicine, Nanning, 530000, People’s Republic of China; 2Department of Dermatology and Venereology,The First Clinical ...
Li M, Wang X, Chen J, Deng T, Lian C
doaj  

Current Management and Unmet Needs in Alopecia Areata: Viewpoint From a Malaysian Perspective. [PDF]

JMIR Dermatol
Mohd Affandi A, Jamil A, Azizan NZ, Yap FB, Leong KF, Heng AYH, Nuraihan S, Tan WC, Selvarajah L, Raja T, Yap EWY, Ch'ng PWB, Teoh TY, Tey MY.   +13 more
europepmc   +1 more source

Pediatric dermatology /

Clinically focused and practical, this diagnostic reference is ideal for anyone who treats children with skin disorders. Over 800 top-quality full-color illustrations, balanced by clear and succinct text, deliver the right amount of clinical detail to ...
Cohen, Bernardauthor.
core  

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

A Prospective, Multicenter, Randomized, Assessor-Blinded Study Assessing the Efficacy and Safety of Injectable Non-Cross-Linked Hyaluronic Acid for Improving Facial Skin Rejuvenation

Clinical, Cosmetic and Investigational Dermatology
Haiyan Cheng,1 Meng Jiang,1 Shan Zhong,1 Xinhai Liu,2 Dongsheng Cao,3 Qiuyuan Feng,4 Yongzhong Li,5 Wei Xu1 1Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Plastic ...
Cheng H, Jiang M, Zhong S, Liu X, Cao D, Feng Q, Li Y, Xu W   +7 more
doaj  

Hotspots and Emerging Trends in JAK Inhibitor Therapy for Vitiligo: A Bibliometric Analysis (2015-2025). [PDF]

J Inflamm Res
Peng Y, Feng J, Lu L, He H, Xie A, Zhang S, Yang L, Liu Y, Wang T.   +8 more
europepmc   +1 more source

Cost‐effectiveness of DPYD genotyping prior to fluoropyrimidine‐based treatment for colorectal cancer in Wales

British Journal of Clinical Pharmacology, EarlyView.
Abstract Background Regulatory guidance in the United Kingdom advises DPYD genotyping prior to fluoropyrimidine‐based treatment. This economic evaluation estimated the costs and outcomes associated with DPYD screening prior to prescribing fluoropyrimidines for colorectal cancer in Wales and also considers additional variants to those included in ...
Catrin O. Plumpton, Sian M. Morgan, Richard A. Adams, Samantha Cox, Angharad A. Rudkin, Megan Fealey, Craig Barrington, Michelle D. Wood, Dyfrig A. Hughes   +8 more
wiley   +1 more source

Morbihan Disease May Induce Nonspecific Inflammatory of Extra-Facial Region: A Case Report and Literature Review

Clinical, Cosmetic and Investigational Dermatology
FeiFang Deng,1,2 Peng Wang2 1Women and Children’s Health Care Hospital of Luohu, Shenzhen, People’s Republic of China; 2Department of Dermatology, Affiliated Nanshan Hospital of Shenzhen University (Shenzhen Nanshan People’s Hospital), Shenzhen ...
Deng F, Wang P
doaj  

Correction: Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel. [PDF]

Dermatol Ther (Heidelb)
Mendes-Bastos P, Lobo I, Pires da Rosa G, Pimenta R, Gonçalo M, Delphi panel.   +5 more
europepmc   +1 more source